Skip to main content
Ipsen logo

Ipsen — Investor Relations & Filings

Ticker · IPN ISIN · FR0010259150 LEI · 549300M6SGDPB4Z94P11 PA Manufacturing
Open in API
Filings indexed 1,378 across all filing types
Latest filing 2017-04-25 AGM Information
Country FR France
Listing PA IPN

About Ipsen

https://www.ipsen.com/

Ipsen is a global biopharmaceutical company focused on innovation and specialty care. The company develops and commercializes transformative medicines to address high unmet medical needs in three key therapeutic areas: oncology, rare diseases, and neuroscience. By leveraging its specialized expertise and strategic partnerships, Ipsen aims to accelerate the development of new therapies and improve health outcomes for patients worldwide. Its strategy is centered on advancing science with purpose to bring innovative treatments from research and development to the market.

Recent filings

Filing Released Lang Actions
Communicated under the obligation to provide permanent information / Other communications
AGM Information Classification · 98% confidence The document explicitly announces the 'publication of the resolutions proposed by its Board of Directors to its next Shareholders' Meeting to be held on June 7, 2017'. It details the specific resolutions, including the approval of a dividend and the nomination/renewal of several Directors. This content directly relates to the agenda and proposals for an Annual General Meeting (AGM). While it mentions the publication of resolutions, the core content is the substance of those resolutions, making AGM-R the most appropriate classification over a simple RPA or RNS, as it contains the actual meeting material content.
2017-04-25 English
Communiqués au titre de l'obligation d'information permanente / Autres communiqués
AGM Information Classification · 99% confidence The document is titled "Résolutions présentées à l'Assemblée Générale annuelle d'Ipsen du 7 juin 2017" (Resolutions presented at the Annual General Meeting of Ipsen of June 7, 2017). It explicitly discusses the resolutions to be submitted to the upcoming Annual General Meeting (AGM), including the approval of a dividend and the nomination/renewal of directors. This content directly relates to the agenda and materials for an AGM. Therefore, the appropriate classification is AGM Information (AGM-R).
2017-04-25 French
Communiqués au titre de l'obligation d'information permanente / Autres communiqués
Board/Management Information Classification · 99% confidence The document is a press release dated April 14, 2017, announcing the appointment of Dr. Alexandre Lebeaut as Executive Vice-President, Research & Development and Chief Scientific Officer. This type of announcement concerns changes in senior management and the board of directors. Based on the provided definitions, this clearly aligns with the 'Board/Management Information' category (Code: MANG). It is not an earnings release, a full annual report, or a proxy statement, but specifically addresses executive leadership changes.
2017-04-14 French
Communicated under the obligation to provide permanent information / Other communications
Board/Management Information Classification · 99% confidence The document is a press release dated April 14, 2017, announcing the appointment of Dr. Alexandre Lebeaut as Executive Vice-President, R&D, and Chief Scientific Officer. This content directly relates to changes in senior management personnel. Based on the provided definitions, this aligns perfectly with the 'Board/Management Information' category (Code: MANG). It is not an earnings release, a full annual report, or a proxy statement.
2017-04-14 English
Information relating to the total number of voting rights and shares making up the capital
Regulatory Filings Classification · 90% confidence The document is titled 'Monthly information regarding the total number of voting rights and total number of shares of the Company' and references Article 223-16 of the AMF General Regulations. It provides a table showing the total number of shares and voting rights as of a specific date (March 31, 2017). This content directly relates to the structure of voting rights and share capital, which is a specific type of regulatory disclosure. While it is a monthly update, it does not fit the definition of a comprehensive Interim Report (IR) or an Annual Report (10-K). It is a specific disclosure related to capital structure and voting rights. Among the provided codes, none perfectly match a 'Monthly Voting Rights Disclosure'. However, since it is a specific regulatory disclosure concerning share capital and voting rights, it is closest in nature to a Capital/Financing Update (CAP) or potentially a general Regulatory Filing (RNS). Given the focus on the total number of shares and voting rights, it is a direct disclosure about the capital structure. Since 'SHA' is for Share Issue/Capital Change (which usually implies an action like a split or new issue), and this is a periodic report on the existing structure, 'RNS' (General regulatory announcements/fallback) is the most appropriate general category for this specific, non-standard periodic disclosure, although it touches upon share capital information.
2017-04-10 English
Information relative au nombre total de droits de vote et d'actions composant le capital
Share Issue/Capital Change Classification · 95% confidence The document is titled "Information mensuelle relative au nombre total des droits de vote et d'actions composant le capital social" (Monthly information relating to the total number of voting rights and shares comprising the share capital). It explicitly references Article 223-16 of the AMF General Regulation (Autorité des Marchés Financiers, the French financial market regulator) and provides a table detailing the total number of shares and voting rights as of a specific date (March 31, 2017). This content directly relates to the structure of the company's capital and voting rights, which aligns best with the 'Share Issue/Capital Change' (SHA) category, as it is a mandatory disclosure regarding the capital structure, or potentially a general regulatory filing (RNS). Given the specific focus on the total number of shares and voting rights, SHA is the most precise fit among the provided options, as it deals with the composition of the share capital.
2017-04-10 French

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.